Oil-based DSRP Microcrystal Suspension
Alternative Name: Oil-based drospirenone (DSRP) microcrystal suspension
Product Details
User: Female
Hormonal: Yes
Delivery Method: Injectable
Duration Type: Short-acting
Active Pharmaceutical Ingredient (API): - drospirenone
- drospirenone
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Bayer HealthCare
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Active Development: No
Additional Information
References: Nippe, S. (2011) Parenteral oil-based drospirenone microcrystal suspensions-Evaluation of physicochemical stability and influence of stabilising agents. Int J Pharm. 416(1): 181-8.
Nippe, S. (2011) Parenteral oil-based drospirenone microcrystal suspensions-Evaluation of physicochemical stability and influence of stabilising agents. Int J Pharm. 416(1): 181-8.